Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review
  • Published:

Cell Culture and Animal Models of Viral Hepatitis. Part I: Hepatitis B

Lab Animal volume 33, pages 37–46 (2004)Cite this article

Abstract

Despite the existence of a preventative vaccine, HBV represents a substantial threat to public health, suggesting the need for research to develop new treatments to combat the disease. The authors review the available in vitro and in vivo models, including recently developed transgenic and chimeric mouse models.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Ganem, D. & Varmus, H.E. The molecular biology of the hepatitis B viruses. Annu. Rev. Biochem. 56, 651–693 (1987).

    Article  CAS  PubMed  Google Scholar 

  2. Encke, J., zu Putlitz, J., Geissler, M. & Wands, J.R. Genetic immunization generates cellular and humoral immune responses against the nonstructural proteins of the hepatitis C virus in a murine model. J. Immunol. 161(9), 4917–4923 (1998).

    Google Scholar 

  3. Neurath, A.R., Kent, S.B., Strick, N. & Parker, K. Identification and chemical synthesis of a host cell receptor binding site on hepatitis B virus. Cell 46(1), 429–436 (1986).

    Article  Google Scholar 

  4. Tuttleman, J.S., Pourcel, C. & Summers, J. Formation of the pool of covalently closed circular viral DNA in hepadnavirus-infected cells. Cell 47(3), 451–460 (1986).

    Article  Google Scholar 

  5. Summers, J. & Mason, W.S. Replication of the genome of a hepatitis B–like virus by reverse transcription of an RNA intermediate. Cell 29(2), 403–415 (1982).

    Article  Google Scholar 

  6. Spandau, D.F. & Lee, C.H. Trans-activation of viral enhancers by the hepatitis B virus X protein. J. Virol. 62(2), 427–434 (1988).

    PubMed Central  Google Scholar 

  7. Standring, D.N., Ou, J.H., Masiarz, F.R. & Rutter, W.J. A signal peptide encoded within the precore region of hepatitis B virus directs the secretion of a heterogeneous population of e antigens in Xenopus oocytes. Proc. Natl. Acad. Sci. USA 85(22), 8405–8409 (1988).

    Article  PubMed Central  Google Scholar 

  8. Bartenschlager, R. & Lohmann, V. Replication of hepatitis C virus. J. Gen. Virol. 81(Pt 7), 1631–1648 (2000).

    Article  Google Scholar 

  9. Gripon, P., Diot, C. & Guguen-Guillouzo, C. Reproducible high level infection of cultured adult human hepatocytes by hepatitis B virus: effect of polyethylene glycol on adsorption and penetration. Virology 192(2), 534–540 (1993).

    Article  PubMed  Google Scholar 

  10. Sprinzl, M.F., Oberwinkler, H., Schaller, H. & Protzer, U. Transfer of hepatitis B virus genome by adenovirus vectors into cultured cells and mice: crossing the species barrier. J. Virol. 75(11), 5108–5118 (2001).

    Article  PubMed  PubMed Central  Google Scholar 

  11. Blumberg, B.S., Alter, H.J. & Visnich, S. A “new” antigen in leukemia sera. JAMA 191, 541–546 (1965).

    Article  CAS  PubMed  Google Scholar 

  12. Blumberg, B.S., Gerstley, B.J., Hungerford, D.A., London, W.T. & Sutnick, A.I. A serum antigen (Australia antigen) in Down's syndrome, leukemia, and hepatitis. Ann. Intern. Med. 66(5), 924–931 (1967).

    Article  Google Scholar 

  13. Prince, A.M. An antigen detected in the blood during the incubation period of serum hepatitis. Proc. Natl. Acad. Sci. USA 60(3), 814–821 (1968).

    Article  PubMed Central  Google Scholar 

  14. Lichter, E.A. Chimpanzee antibodies to Australia antigen. Nature 224(221), 810–811 (1969).

    Article  Google Scholar 

  15. Lander, H.J., Holland, P.V., Alter, H.J., Chanock, R.M. & Purcell, R.H. Antibody to hepatitis-associated antigen. Frequency and pattern of response as detected by radioimmunoprecipitation. JAMA 220(8), 1079–1082 (1972).

    Article  Google Scholar 

  16. MacDonald, D.M., Holmes, E.C., Lewis, J.C. & Simmonds, P. Detection of hepatitis B virus infection in wild-born chimpanzees (Pan troglodytes verus): phylogenetic relationships with human and other primate genotypes. J. Virol. 74(9), 4253–4257 (2000).

    Article  PubMed  PubMed Central  Google Scholar 

  17. Takahashi, K., Brotman, B., Usuda, S., Mishiro, S. & Prince, A.M. Full-genome sequence analyses of hepatitis B virus (HBV) strains recovered from chimpanzees infected in the wild: implications for an origin of HBV. Virology 267(1), 58–64 (2000).

    Article  PubMed  CAS  Google Scholar 

  18. Hu, X., Margolis, H.S., Purcell, R.H., Ebert, J. & Robertson, B.H. Identification of hepatitis B virus indigenous to chimpanzees. Proc. Natl. Acad. Sci. USA 97(4), 1661–1664 (2000).

    Article  PubMed  PubMed Central  Google Scholar 

  19. Prince, A.M. in Hepatitis and Blood Transfusion (eds Vyas, G.N., Perkins, H.A. & Schmid, R.S.) 403–406 (Grune & Stratton, New York, 1972).

    Google Scholar 

  20. Thomssen, R. et al. Infectivity of purified hepatitis B virus particles. N. Engl. J. Med. 296(7), 396 (1977).

    Google Scholar 

  21. Prince, A.M., Vnek, J., Brotman, B., Hashimoto, N. & Van den Ende, M.C. in Viral Hepatitis (eds. Vyas, G.N., Cohn, S.N. & Schmid, R.) 507–523 (Franklin Institute Press, Philadelphia, 1978).

    Google Scholar 

  22. Prince, A.M. and Brotman, B. Perspectives on hepatitis B studies with chimpanzees. ILAR J. 42(2), 85–88 (2001).

    Article  PubMed  Google Scholar 

  23. Horowitz, B. & Prince, A.M. Laboratory and preclinical evaluation of the virus safety of coagulation factor concentrates. Dev. Biol. Stand. 67, 291–302 (1987).

    CAS  PubMed  Google Scholar 

  24. Prince, A.M., Horowitz, B., Horowitz, M.S. & Zang, E. The development of virus-free labile blood derivatives—a review. Eur. J. Epidemiol. 3(2), 103–118 (1987).

    Google Scholar 

  25. Yan, R.Q., Su, J.J., Huang, D.R., Gan, Y.C., Yang, C. & Huang, G.H. Human hepatitis B virus and hepatocellular carcinoma. I. Experimental infection of tree shrews with hepatitis B virus. J. Cancer Res. Clin. Oncol. 122(5), 283–288 (1996).

    Article  PubMed  Google Scholar 

  26. Walter, E., Keist, R., Niederost, B., Pult, I. & Blum, H.E. Hepatitis B virus infection of tupaia hepatocytes in vitro and in vivo. Hepatology 24(1), 1–5 (1996).

    PubMed  Google Scholar 

  27. Glebe, D., Aliakbari, M., Krass, P., Knoop, E.V., Valerius, K.P. & Gerlich, W.H. Pre-S1 antigen-dependent infection of Tupaia hepatocyte cultures with human hepatitis B virus. J. Virol. 77(17), 9511–9521 (2003).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  28. Kock, J., Nassal, M., MacNelly, S., Baumert, T.F., Blum, H.E. & von Weizsacker, F. Efficient infection of primary tupaia hepatocytes with purified human and woolly monkey hepatitis B virus. J. Virol. 75(11), 5084–5089 (2001).

    Article  PubMed  PubMed Central  Google Scholar 

  29. Ren, S. & Nassal, M. Hepatitis B virus (HBV) virion and covalently closed circular DNA formation in primary tupaia hepatocytes and human hepatoma cell lines upon HBV genome transduction with replication-defective adenovirus vectors. J. Virol. 75(3), 1104–1116 (2001).

    Article  PubMed  PubMed Central  Google Scholar 

  30. Li, Y., Su, J.J., Qin, L.L., Yang, C., Ban, K.C. & Yan, R.Q. Synergistic effect of hepatitis B virus and aflatoxin B1 in hepatocarcinogenesis in tree shrews. Ann. Acad. Med. Singapore 28(1), 67–71 (1999).

    Google Scholar 

  31. Yan, R.Q., Su, J.J., Huang, D.R., Gan, Y.C., Yang, C. & Huang, G.H. Human hepatitis B virus and hepatocellular carcinoma. II. Experimental induction of hepatocellular carcinoma in tree shrews exposed to hepatitis B virus and aflatoxin B1. J. Cancer Res. Clin. Oncol. 122(5), 289–295 (1996).

    Article  Google Scholar 

  32. Marion, P.L., Oshiro, L.S., Regnery, D.C., Scullard, G.H. & Robinson, W.S. A virus in Beechey ground squirrels that is related to hepatitis B virus of humans. Proc. Natl. Acad. Sci. USA 77(5), 2941–2945 (1980).

    Article  Google Scholar 

  33. Mason, W.S., Seal, G. & Summers, J. Virus of Pekin ducks with structural and biological relatedness to human hepatitis B virus. J. Virol. 36(3), 829–836 (1980).

    PubMed Central  Google Scholar 

  34. Summers, J., Smolec, J.M. & Snyder, R. A virus similar to human hepatitis B virus associated with hepatitis and hepatoma in woodchucks. Proc. Natl. Acad. Sci. USA 75(9), 4533–4537 (1978).

    Article  Google Scholar 

  35. Summers, J. Three recently described animal virus models for human hepatitis B virus. Hepatology 1(2), 179–183 (1981).

    Article  Google Scholar 

  36. Mason, W.S., Aldrich, C., Summers, J. & Taylor, J.M. Asymmetric replication of duck hepatitis B virus DNA in liver cells: Free minus-strand DNA. Proc. Natl. Acad. Sci. USA 79(13), 3997–4001 (1982).

    Article  Google Scholar 

  37. Cote, P.J. et al. Effects of age and viral determinants on chronicity as an outcome of experimental woodchuck hepatitis virus infection. Hepatology 31(1), 190–200 (2000).

    Article  PubMed  Google Scholar 

  38. Gerin, J.L., Cote, P.J., Korba, B.E. & Tennant, B.C. Hepadnavirus-induced liver cancer in woodchucks. Cancer Detect. Prev. 14(2), 227–229 (1989).

    PubMed  Google Scholar 

  39. Popper, H., Roth, L., Purcell, R.H., Tennant, B.C. & Gerin, J.L. Hepatocarcinogenicity of the woodchuck hepatitis virus. Proc. Natl. Acad. Sci. USA 84(3), 866–870, 1987.

    Article  PubMed Central  Google Scholar 

  40. Baldwin, B.H., Tennant, B.C., Reimers, T.J., Cowan, R.G. & Concannon, P.W. Circannual changes in serum testosterone concentrations of adult and yearling woodchucks (Marmota monax). Biol. Reprod. 32(4), 804–812 (1985).

    Article  Google Scholar 

  41. Ogston, C.W., Jonak, G.J., Rogler, C.E., Astrin, S.M. & Summers, J. Cloning and structural analysis of integrated woodchuck hepatitis virus sequences from hepatocellular carcinomas of woodchucks. Cell 29(2), 385–394 (1982).

    Article  Google Scholar 

  42. Rogler, C.E., Hino, O. & Su, C.Y. Molecular aspects of persistent woodchuck hepatitis virus and hepatitis B virus infection and hepatocellular carcinoma. Hepatology 7(1 Suppl), 74S–78S (1987).

    Article  Google Scholar 

  43. Rogler, C.E. & Summers, J. Cloning and structural analysis of integrated woodchuck hepatitis virus sequences from a chronically infected liver. J. Virol. 50(3), 832–837 (1984).

    PubMed Central  Google Scholar 

  44. Seeger, C. et al. Woodchuck hepatitis virus is a more efficient oncogenic agent than ground squirrel hepatitis virus in a common host. J. Virol. 65(4), 1673–1679 (1991).

    PubMed Central  Google Scholar 

  45. Chu, C.K. et al. Preclinical investigation of L-FMAU as an anti-hepatitis B virus agent. Antivir. Ther. 3(Suppl 3), 113–121 (1998).

    PubMed  Google Scholar 

  46. Korba, B.E. et al. Enhanced antiviral benefit of combination therapy with lamivudine and ?-interferon against WHV replication in chronic carrier woodchucks. Antivir. Ther. 5(2), 95–104 (2000).

    PubMed  Google Scholar 

  47. Korba, B.E., Cote, P., Hornbuckle, W., Schinazi, R., Gerin, J.L. & Tennant, B.C. Enhanced antiviral benefit of combination therapy with lamivudine and famciclovir against WHV replication in chronic WHV carrier woodchucks. Antiviral Res. 45(1), 19–32 (2000).

    Article  PubMed  Google Scholar 

  48. Korba, B.E., Cote, P., Hornbuckle, W., Tennant, B.C. & Gerin, J.L. Treatment of chronic woodchuck hepatitis virus infection in the Eastern woodchuck (Marmota monax) with nucleoside analogues is predictive of therapy for chronic hepatitis B virus infection in humans. Hepatology 31(5), 1165–1175 (2000).

    Article  PubMed  Google Scholar 

  49. Bianchi, L. & Gudat, F. Immunopathology of hepatitis B. Prog. Liver Dis. 6, 371–392 (1979).

    CAS  PubMed  Google Scholar 

  50. Bianchi, L. & Gudat, F. Hepatitis B: viral antigens and histology reflect state of immune response. Pathol. Res. Pract. 164(1), 4–16 (1979).

    Article  Google Scholar 

  51. Chisari, F.V. & Ferrari, C. Hepatitis B virus immunopathogenesis. Annu. Rev. Immunol. 13, 29–60 (1995).

    Article  CAS  PubMed  Google Scholar 

  52. Chisari, F.V. et al. Molecular pathogenesis of hepatocellular carcinoma in hepatitis B virus transgenic mice. Cell 59(6), 1145–1156 (1989).

    Article  Google Scholar 

  53. Sureau, C., Romet-Lemonne, J.L., Mullins, J.I. & Essex, M. Production of hepatitis B virus by a differentiated human hepatoma cell line after transfection with cloned circular HBV DNA. Cell 47(1), 37–47 (1986).

    Article  Google Scholar 

  54. Sells, M.A., Chen, M.L. & Acs, G. Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA. Proc. Natl. Acad. Sci. USA 84(4), 1005–1009 (1987).

    Article  PubMed Central  Google Scholar 

  55. Babinet, C., Farza, H., Morello, D., Hadchouel, M. & Pourcel, C. Specific expression of hepatitis B surface antigen (HBsAg) in transgenic mice. Science 230(4730), 1160–1163 (1985).

    Article  Google Scholar 

  56. Chisari, F.V. et al. A transgenic mouse model of the chronic hepatitis B surface antigen carrier state. Science 230(4730), 1157–1160 (1985).

    Article  Google Scholar 

  57. Farza, H., Hadchouel, M., Scotto, J., Tiollais, P., Babinet, C. & Pourcel, C. Replication and gene expression of hepatitis B virus in a transgenic mouse that contains the complete viral genome. J. Virol. 62(11), 4144–4152 (1988).

    PubMed Central  Google Scholar 

  58. Araki, K. et al. Expression and replication of hepatitis B virus genome in transgenic mice. Proc. Natl. Acad. Sci. USA 86(1), 207–211 (1989).

    Article  Google Scholar 

  59. Guidotti, L.G., Matzke, B., Schaller, H. & Chisari, F.V. High-level hepatitis B virus replication in transgenic mice. J. Virol. 69(10), 6158–6169 (1995).

    PubMed  PubMed Central  Google Scholar 

  60. Chisari, F.V. et al. Structural and pathological effects of synthesis of hepatitis B virus large envelope polypeptide in transgenic mice. Proc. Natl. Acad. Sci. USA 84(19), 6909–6913 (1987).

    Article  PubMed Central  Google Scholar 

  61. Dunsford, H.A., Sell, S. & Chisari, F.V. Hepatocarcinogenesis due to chronic liver cell injury in hepatitis B virus transgenic mice. Cancer Res. 50(11), 3400–3407 (1990).

    Google Scholar 

  62. Hagen, T.M. et al. Extensive oxidative DNA damage in hepatocytes of transgenic mice with chronic active hepatitis destined to develop hepatocellular carcinoma. Proc. Natl. Acad. Sci. USA 91(26), 12808–12812 (1994).

    Article  Google Scholar 

  63. Koike, K. et al. High-level expression of hepatitis B virus HBx gene and hepatocarcinogenesis in transgenic mice. Hepatology 19(4), 810–819 (1994).

    Article  Google Scholar 

  64. Kim, C.M., Koike, K., Saito, I., Miyamura, T. & Jay, G. HBx gene of hepatitis B virus induces liver cancer in transgenic mice. Nature 351(6324), 317–320 (1991).

    Article  PubMed  Google Scholar 

  65. Lee, T.H., Finegold, M.J., Shen, R.F., DeMayo, J.L., Woo, S.L. & Butel, J.S. Hepatitis B virus transactivator X protein is not tumorigenic in transgenic mice. J. Virol. 64(12), 5939–5947 (1990).

    PubMed  PubMed Central  Google Scholar 

  66. Reifenberg, K. et al. Long-term expression of the hepatitis B virus core-e- and X-proteins does not cause pathologic changes in transgenic mice. J. Hepatol. 26(1), 119–130 (1997).

    Article  Google Scholar 

  67. Ueda, H. et al. Functional inactivation but not structural mutation of p53 causes liver cancer. Nat. Genet. 9(1), 41–47 (1995).

    Article  PubMed  Google Scholar 

  68. Moriyama, T. et al. Immunobiology and pathogenesis of hepatocellular injury in hepatitis B virus transgenic mice. Science 248(4953), 361–364 (1990).

    Article  Google Scholar 

  69. Ando, K. et al. Mechanisms of class I restricted immunopathology. A transgenic mouse model of fulminant hepatitis. J. Exp. Med. 178(5), 1541–1554 (1993).

    Article  Google Scholar 

  70. Guidotti, L.G., Ishikawa, T., Hobbs, M.V., Matzke, B., Schreiber, R. & Chisari, F.V. Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes. Immunity 4(1), 25–36 (1996).

    Article  PubMed  Google Scholar 

  71. Tsui, L.V., Guidotti, L.G., Ishikawa, T. & Chisari, F.V. Posttranscriptional clearance of hepatitis B virus RNA by cytotoxic T lymphocyte–activated hepatocytes. Proc. Natl. Acad. Sci. USA 92(26), 12398–12402 (1995).

    Article  PubMed  PubMed Central  Google Scholar 

  72. Heise, T., Guidotti, L.G., Cavanaugh, V.J. & Chisari, F.V. Hepatitis B virus RNA-binding proteins associated with cytokine-induced clearance of viral RNA from the liver of transgenic mice. J. Virol. 73(1), 474–481 (1999).

    PubMed  PubMed Central  Google Scholar 

  73. Nakamoto, Y., Guidotti, L.G., Kuhlen, C.V., Fowler, P. & Chisari, F.V. Immune pathogenesis of hepatocellular carcinoma. J. Exp. Med. 188(2), 341–350 (1998).

    Article  Google Scholar 

  74. Feitelson, M.A., DeTolla, L.J. & Zhou, X.D. A chronic carrierlike state is established in nude mice injected with cloned hepatitis B virus DNA. J. Virol. 62(4), 1408–1415 (1988).

    PubMed Central  Google Scholar 

  75. Larkin, J. et al. Hepatitis B virus transgenic mouse model of chronic liver disease. Nat. Med. 5(8), 907–912 (1999).

    Article  PubMed  CAS  Google Scholar 

  76. Baron, J.L., Gardiner, L., Nishimura, S., Shinkai, K., Locksley, R. & Ganem, D. Activation of a nonclassical NKT cell subset in a transgenic mouse model of hepatitis B virus infection. Immunity 16(4), 583–594 (2002).

    Article  Google Scholar 

  77. Kato, K., Kaneda, Y., Sakurai, M., Nakanishi, M. & Okada, Y. Direct injection of hepatitis B virus DNA into liver induced hepatitis in adult rats. J. Biol. Chem. 266(33), 22071–22074 (1991).

    Google Scholar 

  78. Yang, P.L., Althage, A., Chung, J. & Chisari, F.V. Hydrodynamic injection of viral DNA: a mouse model of acute hepatitis B virus infection. Proc. Natl. Acad. Sci. USA 99(21), 13825–13830 (2002).

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  79. Gupta, S., Aragona, E., Vemuru, R.P., Bhargava, K.K., Burk, R.D. & Chowdhury, J.R. Permanent engraftment and function of hepatocytes delivered to the liver: implications for gene therapy and liver repopulation. Hepatology 14(1), 144–149 (1991).

    Article  Google Scholar 

  80. Ponder, K.P. et al. Mouse hepatocytes migrate to liver parenchyma and function indefinitely after intrasplenic transplantation. Proc. Natl. Acad. Sci. USA 88(4), 1217–1221 (1991).

    Article  Google Scholar 

  81. Brown, J.J. et al. A long-term hepatitis B viremia model generated by transplanting nontumorigenic immortalized human hepatocytes in Rag-2-deficient mice. Hepatology 31(1), 173–181 (2000).

    Article  PubMed  Google Scholar 

  82. Ohashi, K. et al. Sustained survival of human hepatocytes in mice: a model for in vivo infection with human hepatitis B and hepatitis delta viruses. Nat. Med. 6(3), 327–331 (2000).

    Article  PubMed  CAS  Google Scholar 

  83. Guha, C., Deb, N.J., Sappal, B.S., Ghosh, S.S., Roy-Chowdhury, N. & Roy-Chowdhury, J. Amplification of engrafted hepatocytes by preparative manipulation of the host liver. Artif. Organs 25(7), 522–528 (2001).

    Article  Google Scholar 

  84. Sandgren, E.P., Palmiter, R.D., Heckel, J.L., Daugherty, C.C., Brinster, R.L. & Degen, J.L. Complete hepatic regeneration after somatic deletion of an albumin-plasminogen activator transgene. Cell 66(2), 245–256 (1991).

    Article  Google Scholar 

  85. Rhim, J.A., Sandgren, E.P., Palmiter, R.D. & Brinster, R.L. Complete reconstitution of mouse liver with xenogeneic hepatocytes. Proc. Natl. Acad. Sci. USA 92(11), 4942–4946 (1995).

    Article  Google Scholar 

  86. Overturf, K. et al. Hepatocytes corrected by gene therapy are selected in vivo in a murine model of hereditary tyrosinaemia type I [see comments] [published erratum appears in Nat. Genet. 12(4), 458 (1996)]. Nat. Genet. 12(3), 266–273 (1996).

    Article  Google Scholar 

  87. Laconi, E. et al. Long-term, near-total liver replacement by transplantation of isolated hepatocytes in rats treated with retrorsine. Am. J. Pathol. 153(1), 319–329 (1998).

    Article  Google Scholar 

  88. Guha, C. et al. Normal hepatocytes correct serum bilirubin after repopulation of Gunn rat liver subjected to irradiation/partial resection. Hepatology 36(2), 354–362 (2002).

    Article  Google Scholar 

  89. Guha, C. et al. Amelioration of radiation-induced liver damage in partially hepatectomized rats by hepatocyte transplantation. Cancer Res. 59(23), 5871–5874 (1999).

    Google Scholar 

  90. Rhim, J.A., Sandgren, E.P., Degen, J.L., Palmiter, R.D. & Brinster, R.L. Replacement of diseased mouse liver by hepatic cell transplantation. Science 263(5150), 1149–1152 (1994).

    Article  Google Scholar 

  91. Petersen, J., Dandri, M., Gupta, S. & Rogler, C.E. Liver repopulation with xenogeneic hepatocytes in B and T cell-deficient mice leads to chronic hepadnavirus infection and clonal growth of hepatocellular carcinoma. Proc. Natl. Acad. Sci. USA 95(1), 310–315 (1998).

    Article  Google Scholar 

  92. Dandri, M. et al. Repopulation of mouse liver with human hepatocytes and in vivo infection with hepatitis B virus. Hepatology 33(4), 981–988 (2001).

    Article  PubMed  Google Scholar 

  93. Mercer, D.F. et al. Hepatitis C virus replication in mice with chimeric human livers. Nat. Med. 7(8), 927–933 (2001).

    Article  PubMed  CAS  Google Scholar 

  94. Eren, R. et al. Human monoclonal antibodies specific to hepatitis B virus generated in a human/mouse radiation chimera: the Trimera system. Immunology 93(2), 154–161 (1998).

    Google Scholar 

  95. Ilan, E. et al. The hepatitis B virus-trimera mouse: a model for human HBV infection and evaluation of anti-HBV therapeutic agents. Hepatology 29(2), 553–562 (1999).

    Article  PubMed  Google Scholar 

  96. Bocher, W.O. et al. Induction of strong hepatitis B virus (HBV) specific T-helper cell and cytotoxic T lymphocyte responses by therapeutic vaccination in the trimera mouse model of chronic HBV infection. Eur. J. Immunol. 31(7), 2071–2079 (2001).

    Article  Google Scholar 

  97. Wu, C.H., Ouyang, E.C., Walton, C.M. & Wu, G.Y. Human hepatocytes transplanted into genetically immunocompetent rats are susceptible to infection by hepatitis B virus in situ. J. Viral. Hepat. 8(2), 111–119 (2001).

    Article  PubMed  Google Scholar 

  98. Guha, C. et al. Liver irradiation: a potential preparative regimen for hepatocyte transplantation. Int. J. Radiat. Oncol. Biol. Phys. 49(2), 451–457 (2001).

    Article  Google Scholar 

  99. Guidotti, L.G. et al. Cytotoxic T lymphocytes inhibit hepatitis B virus gene expression by a noncytolytic mechanism in transgenic mice. Proc. Natl. Acad. Sci. USA 91(9), 3764–3768 (1994).

    Article  Google Scholar 

  100. Burk, R.D., DeLoia, J.A., elAwady, M.K. & Gearhart, J.D. Tissue preferential expression of the hepatitis B virus (HBV) surface antigen gene in two lines of HBV transgenic mice. J. Virol. 62(2), 649–654 (1988).

    PubMed Central  Google Scholar 

  101. DeLoia, J.A., Burk, R.D. & Gearhart, J.D. Developmental regulation of hepatitis B surface antigen expression in two lines of hepatitis B virus transgenic mice. J. Virol. 63(9), 4069–4073 (1989).

    PubMed Central  Google Scholar 

  102. Chisari, F.V. et al. Expression of hepatitis B virus large envelope polypeptide inhibits hepatitis B surface antigen secretion in transgenic mice. J. Virol. 60(3), 880–887 (1986).

    PubMed Central  Google Scholar 

  103. Wirth, S., Guidotti, L.G., Ando, K., Schlicht, H.J. & Chisari, F.V. Breaking tolerance leads to autoantibody production but not autoimmune liver disease in hepatitis B virus envelope transgenic mice. J. Immunol. 154(5), 2504–2515 (1995).

    Google Scholar 

  104. Milich, D.R., Jones, J.E., Hughes, J.L., Price, J., Raney, A.K. & McLachlan, A. Is a function of the secreted hepatitis B e antigen to induce immunologic tolerance in utero? Proc. Natl. Acad. Sci. USA 87(17), 6599–6603 (1990).

    Article  Google Scholar 

  105. Guidotti, L.G., Martinez, V., Loh, Y.T., Rogler, C.E. & Chisari, F.V. Hepatitis B virus nucleocapsid particles do not cross the hepatocyte nuclear membrane in transgenic mice. J. Virol. 68(9), 5469–5475 (1994).

    PubMed Central  Google Scholar 

  106. Milich, D.R. et al. Extrathymic expression of the intracellular hepatitis B core antigen results in T cell tolerance in transgenic mice. J. Immunol. 152(2), 455–466 (1994).

    Google Scholar 

Download references

Acknowledgements

This work was supported in part by a grant from the American Cancer Society: RPG-00-066-01-CCE (to C.G.) and the following grants from NIH: RO1-DK 46057 (to J.R.C.), RO1-DK 39137 (to N.R.C.), and the Liver Research Core Center grant DK-P30-41296.

Author information

Authors and Affiliations

  1. Albert Einstein College of Medicine, 1300 Morris Park Ave., Bronx, NY

    Chandan Guha MD, PhD, Sankar Mohan PhD, Namita Roy-Chowdhury PhD & Jayanta Roy-Chowdhury MD

Authors
  1. Chandan Guha MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sankar Mohan PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Namita Roy-Chowdhury PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jayanta Roy-Chowdhury MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jayanta Roy-Chowdhury MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Guha, C., Mohan, S., Roy-Chowdhury, N. et al. Cell Culture and Animal Models of Viral Hepatitis. Part I: Hepatitis B. Lab Anim 33, 37–46 (2004). https://doi.org/10.1038/laban0704-37

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/laban0704-37

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing